J&J's (JNJ) Ethicon Agrees to Buy Acclarent for $785M in Cash

December 16, 2009 5:02 PM EST Send to a Friend
Ethicon, Inc., a Johnson & Johnson (NYSE: JNJ) company and a worldwide leader in surgical care, and Acclarent, Inc., a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login